MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$26,711,969 Prepaid expenses andother assets$1,542,116 Property and equipment$295,911 Total current assets$28,254,085 Prepaid expenses$1,996,300 Financing leaseright-of-use assets$123,514 Property and equipment,net$120,184 Less accumulateddepreciation$175,727 Total assets$30,494,083 Total liabilities andstockholders' equity$30,494,083 Total liabilities$21,242,250 Total stockholders'equity$9,251,833 Accumulated deficit-$216,606,504 Note payable, net ofcurrent portion$11,733,350 Total currentliabilities$9,483,214 Financing leaseobligation-long term$25,686 Additional paid-in capital$225,840,226 Common stock, 0.00033par value,...$18,111 Current portion of notespayable$5,130,372 Accounts payable$3,574,448 Accrued expenses$742,227 Financing leaseobligation - short term$36,167
Balance Sheet
source: myfinsight.com

PDS Biotechnology Corp (PDSB)

PDS Biotechnology Corp (PDSB)